Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED NA

Improving Treatment Outcomes for Suicidal Veterans With PTSD

NCT04690582 · View on ClinicalTrials.gov ↗

Study Summary

The efficacy of cognitive processing therapy (CPT) for reducing the symptoms of posttraumatic stress disorder (PTSD) across populations including military personnel and veterans is well supported. CPT also contributes to significant and rapid reductions in suicide ideation among people diagnosed with PTSD, although available evidence suggests this effect decays over time. Studies also show that approximately 1 in 6 people who begin CPT without suicide ideation will subsequently report suicidal thoughts at some point during or soon after completing treatment. Research focused on improving CPT's effects on suicide risk is therefore warranted. The primary aim of this study is to determine if the integration of a crisis response plan (CRP)--an empirically-supported procedure for reducing suicide ideation and attempts--can lead to faster reductions in suicide ideation among acutely suicidal veterans receiving CPT and prevent the development of suicide ideation among veterans who begin CPT without suicide ideation.

Interventions

  • BEHAVIORAL Cognitive Processing Therapy (CPT)
  • BEHAVIORAL Narrative Assessment
  • BEHAVIORAL Crisis Response Plan (CRP)
  • BEHAVIORAL Safety Planning Intervention (SPI)

Study Locations (1)

Ohio

  • The Ohio State University — Columbus

Trial Details

FieldValue
Enrollment Target 157 participants
Start Date 2021-01-15
Est. Completion 2023-12-31
Phase NA

Sponsor

Ohio State University

640 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04690582

The ClinicalTrials.gov registry entry for NCT04690582 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 640 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 3 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 4 interventions — of which Cognitive Processing Therapy (CPT) is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT04690582 reports 1 study location spanning 1 distinct geographic area — top geographies include Ohio. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT04690582 about?

NCT04690582 is a clinical study titled "Improving Treatment Outcomes for Suicidal Veterans With PTSD". The efficacy of cognitive processing therapy (CPT) for reducing the symptoms of posttraumatic stress disorder (PTSD) across populations including military personnel and veterans is well supported. CPT also contributes to significant and rapid reductions in suicide ideation among people diagnosed wit...

What is the current status of trial NCT04690582?

This trial is currently completed. It is a NA study. The enrollment target is 157 participants. The study started on 2021-01-15. Estimated completion is 2023-12-31.

What conditions does trial NCT04690582 study?

This clinical trial studies the following conditions: Suicidal Ideation, Suicide, Attempted, Ptsd. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT04690582?

The interventions under investigation include: Cognitive Processing Therapy (CPT) (BEHAVIORAL), Narrative Assessment (BEHAVIORAL), Crisis Response Plan (CRP) (BEHAVIORAL), Safety Planning Intervention (SPI) (BEHAVIORAL). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT04690582?

This trial is sponsored by Ohio State University, which has 640 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT04690582 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial